Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$308,459,837
+$91,496,212 QoQ
Shares Held
257,172
+9.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
#210
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tredje AP-fonden holds $928,724,025 across 9 Drug Manufacturers - General names. LLY ranks #1 (33.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
257,172 | $308,459,837 | |
| 2 | JNJ |
Johnson & Johnson
|
753,095 | $191,263,537 | |
| 3 | ABBV |
AbbVie Inc.
|
548,411 | $138,002,144 | |
| 4 | MRK |
Merck & Co., Inc.
|
786,562 | $101,073,217 | |
| 5 | AMGN |
Amgen Inc
|
169,380 | $61,335,885 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
321,765 | $40,651,790 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
690,291 | $39,774,567 | |
| 8 | PFE |
Pfizer Inc
|
1,568,204 | $37,762,352 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $308,459,837 | 257,172 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $216,963,625 | 235,889 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $252,462,774 | 234,919 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $178,875,431 | 234,437 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $237,548,515 | 304,733 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $211,906,206 | 256,573 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $185,374,956 | 240,123 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $183,480,831 | 207,103 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $207,597,296 | 229,293 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $170,601,182 | 219,293 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $116,463,335 | 199,793 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $103,463,591 | 192,623 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $89,558,296 | 190,964 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $47,596,981 | 138,597 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $46,617,893 | 127,427 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $28,594,163 | 88,431 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $37,923,561 | 116,965 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $32,349,787 | 112,965 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $26,645,562 | 96,465 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $23,917,371 | 103,516 | Shares | Sole | 2021-11-10 | |
| 2021-03-31 | $51,098,259 | 273,516 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $31,829,041 | 188,516 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $36,785,338 | 248,516 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $62,144,756 | 378,516 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $17,565,003 | 126,622 | Shares | Sole | 2020-05-28 | |
| No filing history on record for this holder in this stock. | ||||||